AI in Healthcare Data Security

🔥 AI Security: The New Frontier of Patient Safety Cybersecurity used to mean protecting devices, networks, and data. In the age of AI, that is no longer enough. The new threat surface is the model itself. AI security now includes: • Model poisoning • Adversarial prompts • Data injection attacks • Synthetic identity creation • Algorithmic manipulation • Compromised training datasets • Unauthorized model extraction • Real-time clinical guidance distortion If your AI is compromised, your patient care is compromised. It’s that simple. Forward-looking healthcare leaders are pivoting from: “Protect the system” → to → “Protect the intelligence behind the system.” What we protect must now include: ✔️ Model integrity ✔️ Training data lineage ✔️ API security ✔️ Prompt security ✔️ Real-time monitoring of drift ✔️ Audit trails for algorithmic decisions ✔️ Red-team testing for AI vulnerabilities In 2026, AI security will become the new patient safety. Leaders who don’t understand AI risk cannot ensure clinical safety. — Khalid Turk MBA, PMP, CHCIO, FCHIME Building systems that work, teams that thrive, and cultures that endure.

AI in healthcare poses unique patient safety risks, but this study proposes 14 practical software design requirements to reduce them, structured around reliability, transparency, traceability, and responsibility. 1️⃣ AI systems should undergo continuous performance evaluation post-deployment, not just during development. 2️⃣ Usability testing and strong cybersecurity measures (e.g., encryption, field-tested libraries) are essential for real-world safety. 3️⃣ Semantic interoperability with EHRs (using HL7 or openEHR) ensures AI integrates smoothly into clinical environments. 4️⃣ An AI passport, a kind of datasheet explaining purpose, context, training, and known biases, boosts transparency. 5️⃣ Explainable AI (XAI) tools and bias detection techniques help clinicians trust and validate model outputs. 6️⃣ Assessing data quality across multiple dimensions (e.g., completeness, temporal stability) is key for safe AI predictions. 7️⃣ Traceability requires user access logs, audit trails, and regular case reviews to catch issues early. 8️⃣ Regulatory compliance checks, academic-use disclaimers, and clinician sign-offs clarify responsibility and legal status. 9️⃣ A sector survey of 216 professionals (clinicians, technicians, users, and decision-makers) rated these requirements as essential, especially AI explainability, data quality, audit trails, and regulatory safeguards. 🔟 Clinicians valued practical protections (e.g., performance tracking, encryption) more than technicians, while users rated transparency tools (e.g., AI passport) higher than decision-makers. ✍🏻 Juan M Garcia-Gomez, Vicent Blanes Selva-Selva, Celia Alvarez Romero, Jose Carlos de Bartolomé Cenzano, Felipe Pereira, Alejandro Pazos, Ascensión Doñate-Martínez. Mitigating patient harm risks: A proposal of requirements for AI in healthcare. Artificial Intelligence in Medicine. 2025. DOI: 10.1016/j.artmed.2025.103168

🏥 First there was HL7. Then FHIR. Now healthcare 🤝 Model Context Protocol (MCP). Is this the future of healthcare AI governance? In healthcare, AI governance can’t just be about compliance checklists. Patients’ lives, privacy, and trust are on the line. This is where the Model Context Protocol (MCP) comes in. By standardizing how AI models interact with sensitive data and clinical tools, MCP could transform governance in healthcare: ✅ Data Boundaries – Ensures AI can only access authorized patient records or medical knowledge bases ✅ Transparency – Every query and response is logged, making clinical decisions auditable ✅ Interoperability – Works across different EHR systems, devices, and APIs without vendor lock-in ✅ Real-Time Accountability – Governance isn’t after-the-fact; it’s embedded in the workflow itself Imagine a clinical decision support AI: with MCP, governance isn’t just “was the recommendation safe?”—it’s “did the model even have the right to access this data or trigger this workflow?” This shifts healthcare AI oversight from reactive investigation to governance-by-design, aligning with HIPAA, FDA, and future regulatory frameworks. 💡 The result? Greater trust from clinicians, patients, and regulators—because safety and ethics are hardwired into the protocol layer itself. 👉 Will MCP become the backbone for safe, compliant AI in healthcare? Thoughts?

AI adoption in hospitals is accelerating, but privacy exposure is uneven across departments. Radiology, clinical research, and patient intake face the highest breach risk because they handle continuous identifiable data flows. What this means for leadership: • Risk is not just technical, it impacts trust, accreditation, reimbursement, and patient safety. • Safeguards must be tailored to workflows, not applied as generic system-wide policies. • Privacy-preserving architectures (federated learning, differential privacy, secure audit trails) need to be operationalized at the department level) • Continuous training matters as much as encryption. Healthcare systems that manage privacy well will scale AI responsibly and maintain public confidence. Those that overlook operational exposure will face regulatory and reputational shocks. 🔔 Follow Rizwan Tufail for evidence-based frameworks to deploy AI with safety, governance, and institutional trust at the core.

Healthcare has had a compliance requirement for thirty years that AI agents violate by default. It's called the minimum necessary standard, and every Copilot deployment touching patient records is testing it right now. The minimum necessary standard is one of HIPAA's foundational Privacy Rule requirements. It demands that access to protected health information be limited to exactly what the specific task requires. Not what the system can reach. Not what permissions allow. What the task requires. Every covered entity and business associate in the United States is bound by it. The problem is that standard was written for a world where a human being made every access decision. The physician reviewing a record. The billing specialist pulling a chart. A person who understood the patient relationship, the purpose of the request, and the regulatory obligation attached to it. That judgment was never codified in a label or a permission entry. It lived in the person doing the work. When a health system deploys Copilot across administrative workflows or an AI agent across revenue cycle operations, that person steps back. The agent has the access. It does not have the judgment. And the most dangerous failure mode isn't an unauthorized party reaching patient records. It's an authorized agent surfacing psychiatric history in a billing workflow, or pulling a complete episode record when a single encounter note was the only appropriate scope. No unauthorized access occurs. The minimum necessary standard is violated anyway. In January 2025, HHS published a proposed major update to the HIPAA Security Rule — the first of its kind in roughly two decades — signaling that AI systems operating across clinical and administrative workflows are squarely inside the compliance framework, not a future consideration. The full piece is in the comments. Curious whether compliance teams at the health systems you work with have confronted this distinction yet. #AISecurity #DataSecurity #HIPAA #HealthcareAI #AIGovernance #CISO #DataProtection #Cybersecurity #AIRisk

“Will this AI vendor walk us into a breach or a ransomware headline?” With so many new AI tools popping up every day, I fear that some healthcare companies could be opening the door to a nightmare scenario. Too many “healthcare AI” tools started life as generic or consumer apps and got a HIPAA label bolted on later. Same shortcuts, same blind spots, radically higher stakes when PHI is involved. Red flags I watch for when evaluating new technology: 🚩 Hand‑waving when you ask, “Where does PHI actually go, and who touches it?” 🚩 Big “bank‑grade security” language with no independent validation or real audit reports. 🚩 No concrete plan for what happens in the first 72 hours of a breach, just vague assurances and boilerplate contract language. 🚩 Engineering cultures that celebrate shipping fast, but go quiet when you ask about logging, segregation of duties, backups, or ransomware playbooks. That combination is exactly how a “small” AI pilot turns into a VERY bad day: 🚨 Core clinical or revenue workflows suddenly stall while systems are taken offline to contain an incident. 🚨 Weeks of manual workarounds and delayed payments pile up, burning out staff and crushing cash flow. 🚨 Patients learn their most sensitive details may be exposed, and you are the one standing in front of cameras and regulators explaining why you trusted the wrong partner. Good technology partners are boring in all the right ways: clear data flows, real certifications, documented governance, named security owners, tested incident response, and contracts that spell out who does what when things go wrong. They ASSUME they will be targeted and design for resilience, not just demos. In healthcare, a “risky AI vendor” is not just a tech decision. It is a bet on who will be standing beside you when something breaks: a partner with receipts, or a logo that vanishes the moment the ransom note appears. #healthcareai #aisecurity #healthcaretechnology

The "Chatbot" Era is Over. The "Agent" Era is Here—and Healthcare Isn’t Ready. We’ve spent the last two years worrying about Prompt Injection (what an AI says). In 2026, we have a much bigger problem: Agency Abuse (what an AI does). In healthcare, an AI agent isn't just a search tool; it's a "clinical colleague" with the power to: ➡️ Verify insurance and authorize claims. ➡️ Access PHI (Protected Health Information) via EHR integrations. ➡️ Draft clinical notes and suggest diagnostic codes…. Just to name a few things our new colleague might be doing.   Access Control is Failing: Traditional security relies on Zero Trust—the "Never Trust, Always Verify" model that checks if an agent has permission to access a database. But in an agentic world, permissions aren't the problem. Intent is. If a scheduling agent is tricked into exfiltrating a patient's historical records, it isn't "breaking in"—it's using its valid permissions for a malicious purpose. That isn't a breach; it's Agency Abuse.   Why "Observability" is the New "Security" You can’t "firewall" an autonomous agent’s reasoning. To protect patient safety and stay HIPAA/HITRUST compliant, we must move from static access control to Deep AI Observability (or as I like to call it – “pervasive & ruthless") ☑️ Audit the "Why," not just the "What": We need to see the "Chain of Thought" behind every medical recommendation to ensure it aligns with clinical guidelines, not cost-cutting shortcuts. ☑️ Behavioral Baselines: Security teams must flag when an agent's data access patterns shift from "Reviewing Today's Appointments" to "Bulk Querying Rare Diseases". ☑️ Intent Validation: Before an agent executes a high-stakes action—like clinical coding or treatment suggestions—its intent must be validated against the "Minimum Necessary" standard. The Call to Action for Healthcare Leaders ✅ Stop treating AI agents like software and start treating them like medical staff. ✅ Adopt the OWASP Top 10 for Agentic Applications: Move beyond output filtering and start monitoring for ASI03: Identity and Privilege Abuse. ✅ Verify Intent, Not Just Identity: Implement observability tools that provide an "X-ray" into the agent's decision-making process before it touches a patient record. ✅ Human-in-the-Loop is Regulatory: Under the 2025 HITRUST v11.6 and the EU AI Act, autonomous medical decisions without clear auditability are a liability, not an efficiency. The question for 2026 isn't "Is your AI secure?" it’s "Do you know what your AI is intending to do right now?" #HealthcareAI #AIObservability #AgencyAbuse #HIPAA2025 #HealthTech #AIagentSecurity #ZeroTrust  

I appreciate being included in this piece from For The Record Magazine on AI and healthcare cybersecurity risk. The industry is moving fast on AI. Faster than governance, faster than visibility, and in many cases faster than security can keep up. One important point I emphasized in the article: the issue is not AI. It is how quickly sensitive data is being connected to new tools without clear ownership, access boundaries, or visibility into downstream use. That is the real shift happening right now. AI is not introducing entirely new risk. It is accelerating existing gaps, especially around data governance, access control, and visibility. What used to be manageable at human speed now scales instantly. In healthcare, that becomes even more critical. Data sprawl, complex systems, and expanding vendor ecosystems create an environment where small gaps turn into large exposures very quickly. The takeaway is simple: if you do not know where your sensitive data is, who can access it, and how AI systems are interacting with it, you are already behind. Worth the read for anyone thinking through AI risk, data security, and what needs to change next: https://lnkd.in/gEDj5FiJ

The Enterprise AI Map: Day 25/30 AI governance in healthcare: HIPAA was not designed for this. HIPAA created a framework for protecting health information. It works well for traditional data systems: electronic health records, billing platforms, lab systems. These are defined environments with clear data boundaries. AI tools break those boundaries. When does AI usage trigger HIPAA requirements? > The moment a healthcare worker pastes protected health information (PHI) into an AI tool, HIPAA's Security Rule and Privacy Rule are triggered. This includes patient names, dates of service, diagnosis codes, treatment notes, or any of the 18 HIPAA identifiers. The BAA question. > Under HIPAA, any entity that creates, receives, maintains, or transmits PHI on behalf of a covered entity is a business associate. If an AI tool processes PHI, the vendor needs a Business Associate Agreement. Most consumer AI tools (personal ChatGPT accounts, free AI assistants) do not offer BAAs. Using them with PHI is a HIPAA violation. Clinical vs. administrative AI. > Healthcare organizations need to distinguish between clinical AI use (diagnostic support, treatment recommendations, clinical decision support) and administrative AI use (scheduling, documentation, billing). Clinical AI faces additional regulatory scrutiny under FDA guidance and state medical practice acts. Administrative AI is lower risk but still requires HIPAA compliance if PHI is involved. The unique challenge. > Healthcare workers are among the most time-pressured professionals in any industry. AI tools that save them 30 minutes a day are incredibly valuable. Banning AI in healthcare means telling clinicians to be less efficient with their time. The answer has to be governance, not prohibition. At Oximy, we provide BAAs at no additional cost as part of our standard offering. Healthcare organizations need governance infrastructure that meets HIPAA requirements out of the box, not as an add-on. #EnterpriseAIMap #AIGovernance #Healthcare #HIPAA

A child stands inside a room, looking through a window at other children playing freely outside. The outside represents AI: fast, creative, unconstrained, and accelerating discovery, care delivery, and business models across life sciences and digital health. Inside is regulated healthcare, where patient safety, privacy, compliance, and intellectual property protection are non-negotiable. That tension defines where we are today. AI is rapidly becoming a force multiplier across drug discovery, clinical trials, virtual care, patient engagement, and healthcare operations. But for CEOs and leadership teams, the conversation cannot stop at productivity gains. The same tools driving unprecedented efficiency, ChatGPT, Claude, Grok, Microsoft Copilot, and others, also introduce meaningful compliance, privacy, and IP risks when deployed without proper governance. Consider what may inadvertently enter a prompt: 🔹 Clinical trial data 🔹 Patient information and PHI 🔹 Proprietary research protocols 🔹 Digital health workflows and algorithms 🔹 Regulatory submissions 🔹 Trade secrets and competitive strategy Without safeguards, organizations risk: ⚠️ HIPAA violations ⚠️ FDA scrutiny ⚠️ Intellectual property leakage ⚠️ Cybersecurity vulnerabilities ⚠️ Loss of competitive advantage The opportunity is not to shut the window. It is to design it differently—allowing organizations to benefit from AI while maintaining control, compliance, and trust. Forward-thinking life sciences and digital health companies are increasingly exploring private AI environments, secure enterprise deployments, and governance frameworks that protect sensitive data and regulated workflows. I'm also exploring product concepts focused on secure, private, and air-gapped AI environments designed specifically for regulated industries. If your organization is navigating these challenges—or interested in discussing private or air-gapped AI architectures—I would welcome the conversation. The winners won't simply be the companies that use AI. They will be the companies that successfully balance innovation, compliance, security, and trust. #ArtificialIntelligence #LifeSciences #DigitalHealth #HealthcareInnovation #GenerativeAI #HealthTech #Compliance #HIPAA #FDA #Cybersecurity #AIGovernance #PrivateAI #EnterpriseAI